Our country is facing an obesity epidemic. As a physician I see the repercussions on a daily basis, larger and larger patients with increasing comorbidities, diabetes, hypertension, sleep apnea, ect. Lorcaserin offers real hope to both physicians and patients alike. This medication has been extensively tested and is both safe, effective and desperately needed. I urge the DEA to finalize your decision as soon as possible. Physicians and patients need access to this medication, time is of the essence.
Comment on FR Doc # 2012-30531
This is comment on Proposed Rule
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
View Comment
Related Comments
View AllPublic Submission Posted: 12/21/2012 ID: DEA-2012-0007-0003
Jan 18,2013 11:59 PM ET
Public Submission Posted: 12/21/2012 ID: DEA-2012-0007-0004
Jan 18,2013 11:59 PM ET
Public Submission Posted: 12/21/2012 ID: DEA-2012-0007-0005
Jan 18,2013 11:59 PM ET
Public Submission Posted: 12/21/2012 ID: DEA-2012-0007-0008
Jan 18,2013 11:59 PM ET
Public Submission Posted: 01/04/2013 ID: DEA-2012-0007-0032
Jan 18,2013 11:59 PM ET